Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367300178> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W4367300178 endingPage "233" @default.
- W4367300178 startingPage "224" @default.
- W4367300178 abstract "Background: Patients with chronic myeloid leukemia (CML) now have an improved life expectancy similar to that of the general population due to the introduction of tyrosine kinase inhibitors (TKIs). However, many patients experience mild to severe adverse events while undergoing TKI treatment. This review aimed to discuss the adverse events of TKIs, including myocardial infarction and hypertension, and comprehensively analyze strategies for minimizing vascular complications.Current Concepts: Near-fatal cardiovascular events (CVEs) are common among patients receiving nilotinib and ponatinib. However, those receiving other TKIs, such as imatinib and dasatinib, rarely experience CVEs. Among these CVEs, vascular complications, including peripheral arterial occlusion, venous occlusion, and hypertension, are exacerbated in patients with pre-existing vascular risk factors and prolonged TKI use. Therefore, it is crucial to assess predisposing factors to vascular complications and select the optimal TKI to minimize serious CVEs before initiating therapy. Additionally, patients should be closely monitored for vascular complications during nilotinib and ponatinib treatment.Discussion and Conclusion: Despite advancements in therapeutic approaches and research on CML leading to the development of target-specific TKIs aiming to minimize side effects, newer generations are not entirely devoid of adverse events. Hence, it is important for patients and physicians to be knowledgeable about these medications to effectively monitor for side effects, particularly those that are life-threatening, such as vascular toxicity. It is now more important than ever to carefully observe symptoms and perform adequate testing to identify at-risk individuals early and avoid preventable adverse events." @default.
- W4367300178 created "2023-04-29" @default.
- W4367300178 creator A5028550753 @default.
- W4367300178 creator A5069793777 @default.
- W4367300178 date "2023-04-10" @default.
- W4367300178 modified "2023-10-18" @default.
- W4367300178 title "Vascular complications in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors" @default.
- W4367300178 cites W1939978733 @default.
- W4367300178 cites W1977996924 @default.
- W4367300178 cites W2000846629 @default.
- W4367300178 cites W2006917576 @default.
- W4367300178 cites W2028959752 @default.
- W4367300178 cites W2051566553 @default.
- W4367300178 cites W2061613118 @default.
- W4367300178 cites W2072625253 @default.
- W4367300178 cites W2075706560 @default.
- W4367300178 cites W2125922540 @default.
- W4367300178 cites W2130054182 @default.
- W4367300178 cites W2140259730 @default.
- W4367300178 cites W2143939343 @default.
- W4367300178 cites W2148092884 @default.
- W4367300178 cites W2153431376 @default.
- W4367300178 cites W2260921597 @default.
- W4367300178 cites W2473480037 @default.
- W4367300178 cites W2498545123 @default.
- W4367300178 cites W2600728645 @default.
- W4367300178 cites W2740029254 @default.
- W4367300178 cites W2790692615 @default.
- W4367300178 cites W2800361199 @default.
- W4367300178 cites W2924353663 @default.
- W4367300178 cites W2994916398 @default.
- W4367300178 cites W3004564242 @default.
- W4367300178 cites W3005688782 @default.
- W4367300178 cites W3009751715 @default.
- W4367300178 cites W3108545255 @default.
- W4367300178 cites W3119368005 @default.
- W4367300178 cites W3172509554 @default.
- W4367300178 cites W3194203975 @default.
- W4367300178 cites W3195243079 @default.
- W4367300178 cites W4318485463 @default.
- W4367300178 doi "https://doi.org/10.5124/jkma.2023.66.4.224" @default.
- W4367300178 hasPublicationYear "2023" @default.
- W4367300178 type Work @default.
- W4367300178 citedByCount "0" @default.
- W4367300178 crossrefType "journal-article" @default.
- W4367300178 hasAuthorship W4367300178A5028550753 @default.
- W4367300178 hasAuthorship W4367300178A5069793777 @default.
- W4367300178 hasBestOaLocation W43673001781 @default.
- W4367300178 hasConcept C126322002 @default.
- W4367300178 hasConcept C170493617 @default.
- W4367300178 hasConcept C177713679 @default.
- W4367300178 hasConcept C197934379 @default.
- W4367300178 hasConcept C2777413986 @default.
- W4367300178 hasConcept C2777583451 @default.
- W4367300178 hasConcept C2778729363 @default.
- W4367300178 hasConcept C2779536868 @default.
- W4367300178 hasConcept C2780381907 @default.
- W4367300178 hasConcept C2908647359 @default.
- W4367300178 hasConcept C42362537 @default.
- W4367300178 hasConcept C71924100 @default.
- W4367300178 hasConcept C99454951 @default.
- W4367300178 hasConceptScore W4367300178C126322002 @default.
- W4367300178 hasConceptScore W4367300178C170493617 @default.
- W4367300178 hasConceptScore W4367300178C177713679 @default.
- W4367300178 hasConceptScore W4367300178C197934379 @default.
- W4367300178 hasConceptScore W4367300178C2777413986 @default.
- W4367300178 hasConceptScore W4367300178C2777583451 @default.
- W4367300178 hasConceptScore W4367300178C2778729363 @default.
- W4367300178 hasConceptScore W4367300178C2779536868 @default.
- W4367300178 hasConceptScore W4367300178C2780381907 @default.
- W4367300178 hasConceptScore W4367300178C2908647359 @default.
- W4367300178 hasConceptScore W4367300178C42362537 @default.
- W4367300178 hasConceptScore W4367300178C71924100 @default.
- W4367300178 hasConceptScore W4367300178C99454951 @default.
- W4367300178 hasIssue "4" @default.
- W4367300178 hasLocation W43673001781 @default.
- W4367300178 hasOpenAccess W4367300178 @default.
- W4367300178 hasPrimaryLocation W43673001781 @default.
- W4367300178 hasRelatedWork W1554937972 @default.
- W4367300178 hasRelatedWork W2163329109 @default.
- W4367300178 hasRelatedWork W2184746615 @default.
- W4367300178 hasRelatedWork W2266796555 @default.
- W4367300178 hasRelatedWork W2296146218 @default.
- W4367300178 hasRelatedWork W2318404487 @default.
- W4367300178 hasRelatedWork W2321213113 @default.
- W4367300178 hasRelatedWork W2489068494 @default.
- W4367300178 hasRelatedWork W3036978401 @default.
- W4367300178 hasRelatedWork W3116441850 @default.
- W4367300178 hasVolume "66" @default.
- W4367300178 isParatext "false" @default.
- W4367300178 isRetracted "false" @default.
- W4367300178 workType "article" @default.